Schear Investment Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$999K Buy
3,933
+30
+0.8% +$6.99K 0.33% 57
2026
Q1
$954K Hold
3,903
0.42% 56
2025
Q4
$808K Sell
3,903
-19
-0.5% -$3.76K 0.35% 62
2025
Q3
$727K Buy
3,922
+7
+0.2% +$1.2K 0.32% 71
2025
Q2
$598K Sell
3,915
-117
-3% -$18K 0.3% 73
2025
Q1
$669K Sell
4,032
-13
-0.3% -$2.03K 0.39% 67
2024
Q4
$585K Sell
4,045
-666
-14% -$103K 0.31% 69
2024
Q3
$763K Buy
4,711
+304
+7% +$48.4K 0.47% 65
2024
Q2
$644K Sell
4,407
-319
-7% -$47.4K 0.47% 64
2024
Q1
$748K Sell
4,726
-2,122
-31% -$338K 0.6% 58
2023
Q4
$1.07M Buy
6,848
+22
+0.3% +$3.37K 1.04% 32
2023
Q3
$1.06M Sell
6,826
-639
-9% -$105K 1.15% 29
2023
Q2
$1.24M Buy
7,465
+16
+0.2% +$2.58K 1.31% 24
2023
Q1
$1.15M Buy
7,449
+149
+2% +$24.1K 1.38% 23
2022
Q4
$1.29M Buy
+7,300
New +$1.26M 1.59% 19

Other funds holding JNJ

Schear Investment Advisers's JNJ Position: Q2 2026 in Review

Schear Investment Advisers increased its Johnson & Johnson (JNJ) stake by 0.77% in Q2 2026, buying an estimated $6.99K and bringing the position to 3,933 shares worth $999K. The position accounts for 0.33% of the portfolio, ranked #57.

Schear Investment Advisers first reported a position in JNJ in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.29M in Q4 2022. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Schear Investment Advisers held 3,933 shares of Johnson & Johnson worth $999K as of Q2 2026.
  • Schear Investment Advisers bought 30 Johnson & Johnson shares in Q2 2026, an estimated $6.99K.
  • Johnson & Johnson made up 0.33% of Schear Investment Advisers's portfolio in Q2 2026, its #57 holding.
  • Schear Investment Advisers first reported a position in Johnson & Johnson in Q4 2022 and has held it in 15 quarters since.
  • Schear Investment Advisers's Johnson & Johnson position peaked at $1.29M in Q4 2022.
  • 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Schear Investment Advisers's 13F filing for Q2 2026, filed 27 Jul 2026.